Sesaminol Inhibits Adipogenesis by Suppressing Mitotic Clonal Expansion and Activating the Nrf2-ARE Pathway
Nutrients · 2025
DOI: 10.3390/nu17203242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Saki Nakamatsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Graduate School of Human Life and Ecology, Osaka Metropolitan University, Osaka 538-8525, Japan. Hauptthemen laut MEDLINE: Adipogenesis, NF-E2-Related Factor 2, Dioxoles, Mitosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science (JSPS) KAKENHI.
Abstract (Originalsprache)
Background
As a key contributor to metabolic disorders, obesity is recognized as a critical global health challenge. Adipocyte differentiation depends on the mitotic clonal expansion (MCE) phase, which is controlled by oxidative balance and transcription factors like C/EBPβ. Sesaminol, a lignan derived from Sesamum indicum, has potent antioxidant properties. This study aimed to investigate whether sesaminol suppresses adipogenesis by modulating ROS signaling, MCE, and the Nrf2-ARE pathway.
Methods
In the early period of adipogenic induction, 3T3-L1 preadipocytes received treatment with sesaminol. Adipogenic development was evaluated through Oil Red O staining together with the assay of GPDH activity. Assays of cell proliferation and expression of cell cycle-related proteins, along with ROS measurement, qRT-PCR, Western blotting, and immunofluorescence, were performed to evaluate the effects on oxidative stress, transcriptional regulation, and AMPK-Nrf2 signaling.
Results
Sesaminol significantly inhibited lipid accumulation and GPDH activity without cytotoxicity. It suppressed MCE by inhibiting DNA synthesis and reducing the expression of cyclin E1/E2 and CDK2. Sesaminol decreased C/EBPβ expression and its nuclear localization, resulting in lower levels of C/EBPα and PPARγ. It also reduced intracellular ROS, promoted nuclear translocation of Nrf2, and upregulated antioxidant genes HO-1 and GCLC. AMPK phosphorylation was concurrently enhanced.
Conclusions
Sesaminol inhibits early adipogenesis by suppressing ROS-mediated MCE and activating the AMPK-Nrf2-ARE signaling pathway, leading to downregulation of key adipogenic transcription factors. The present study supports the potential of sesaminol as an effective strategy for obesity prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, Graduate School of Human Life and Ecology, Osaka Metropolitan University, Osaka 538-8525, Japan.
- Department of Nutrition, Aomori University of Health and Welfare, Aomori 030-8505, Japan.
- Kiyomoto Co., Ltd., Miyazaki 889-0595, Japan.
ORCID-Profile: Toshio Norikura, Akiko Kojima-Yuasa
Förderung
- Japan Society for the Promotion of Science
- Japan Society for the Promotion of Science (JSPS) KAKENHI
Zitieren
APA
Nakamatsu, S., Nakata, M., Norikura, T., Sasaki, Y., Matsui-Yuasa, I., Omura, A., Kiyomoto, K., & Kojima-Yuasa, A. (2025). Sesaminol Inhibits Adipogenesis by Suppressing Mitotic Clonal Expansion and Activating the Nrf2-ARE Pathway. Nutrients. https://doi.org/10.3390/nu17203242
Vancouver
Nakamatsu S, Nakata M, Norikura T, Sasaki Y, Matsui-Yuasa I, Omura A, et al. Sesaminol Inhibits Adipogenesis by Suppressing Mitotic Clonal Expansion and Activating the Nrf2-ARE Pathway. Nutrients. 2025. doi:10.3390/nu17203242
BibTeX
@article{Nakamatsu2025,
author = {Nakamatsu, Saki and Nakata, Miki and Norikura, Toshio and Sasaki, Yutaro and Matsui-Yuasa, Isao and Omura, Ayano and Kiyomoto, Kunio and Kojima-Yuasa, Akiko},
title = {Sesaminol Inhibits Adipogenesis by Suppressing Mitotic Clonal Expansion and Activating the Nrf2-ARE Pathway},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17203242}
}
EUVIMED